4D Molecular Therapeutics, Inc.

FDMT · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$48,555$77,159$133,526$149,336
Short-Term Investments$256,508$216,066$187,911$275,541
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$7,314$10,062$11,129$10,055
Total Curr. Assets$312,377$303,287$332,566$434,932
Property Plant & Equip (Net)$35,060$37,154$39,116$40,608
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$67,165$123,806$137,004$80,583
Tax Assets$0$0$0$0
Other NC Assets$9,380$9,390$7,043$4,261
Total NC Assets$111,605$170,350$183,163$125,452
Other Assets$0$0$0$0
Total Assets$423,982$473,637$515,729$560,384
Liabilities
Payables$6,863$8,700$4,151$4,386
Short-Term Debt$5,695$5,721$5,679$5,637
Tax Payable$0$0$0$0
Deferred Revenue$360$1,066$866$257
Other Curr. Liab.$24,189$19,190$16,203$18,869
Total Curr. Liab.$37,107$34,677$26,899$29,149
LT Debt$16,568$17,356$18,174$18,969
Deferred Rev, NC$835$219$434$1,057
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$489$495$499$603
Total NC Liab.$17,892$18,070$19,107$20,629
Other Liabilities$0$0$0$0
Cap. Leases$22,263$23,077$23,853$24,606
Total Liabilities$54,999$52,747$46,006$49,778
Equity
Pref Stock$0$0$0$0
Common Stock$5$5$5$5
Retained Earnings-$735,701-$678,825-$624,167-$576,195
AOCI$671$337$332$229
Other Equity$1,104,008$1,099,373$1,093,553$1,086,567
Total Equity$368,983$420,890$469,723$510,606
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$423,982$473,637$515,729$560,384
Net Debt-$26,292-$54,082-$109,673-$124,730